Dantrolene과 수술 후 고열
Dantrolene and Post-operative Hyperthermia
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Malignant hyperthermia is a rare, fatal pharmacogenetic disorder that occurs during general anesthesia following exposure to a depolarizing muscle relaxant, such as succinylcholine, or volatile anesthetics. Clinical findings in malignant hyperthermia include muscle rigidity, sinus tachycardia, increased CO2 production, skin cyanosis with mottling, and marked hyperthermia. For treatment, cooling techniques must be accompanied by discontinuation of the provocative medication. Furthermore, dantrolene administration is the mainstay of treatment for malignant hyperthermia, and should be initiated as soon as the diagnosis is suspected. We recently experienced a case with post-operative fever of 41.0℃ refractory to conventional anti-pyretic measures and finally resolved with dantrolene administration, in a patient with methicillin-sensitive Staphylococcus aureus monoarthritis of the knee and rapid progression of diffuse septic pneumonia requiring mechanical ventilation.
Abstract
Malignant hyperthermia is a rare, fatal pharmacogenetic disorder that occurs during general anesthesia following exposure to a depolarizing muscle relaxant, such as succinylcholine, or volatile anesthetics. Clinical findings in malignant hyperthermia include muscle rigidity, sinus tachycardia, increased CO2 production, skin cyanosis with mottling, and marked hyperthermia. For treatment, cooling techniques must be accompanied by discontinuation of the provocative medication. Furthermore, dantrolene administration is the mainstay of treatment for malignant hyperthermia, and should be initiated as soon as the diagnosis is suspected. We recently experienced a case with post-operative fever of 41.0℃ refractory to conventional anti-pyretic measures and finally resolved with dantrolene administration, in a patient with methicillin-sensitive Staphylococcus aureus monoarthritis of the knee and rapid progression of diffuse septic pneumonia requiring mechanical ventilation.
참고문헌 (20)
- Nakamura N, "Malignant hyperthermia developing during esophageal resection in an 82-year-old man", J Anesth, 22, pp.464~466 (2008)
- Cho EC, "Malignant hyperthermia during general anesthesia: two cases", Korean J Crit Care Med, 12, pp.89~94 (1997)
- 이정우, "Clinical Grading Scale을 적용한 악성고열증 증례보고의 재평가", Korean Journal of Anesthesiology, 54(6), pp.640~645 (2008), 대한마취과학회
- Strazis KP, "Malignant hyperthermia: a review of published cases", Anesth Analg, 77, pp.297~304 (1993)
- Denborough MA, "Anaesthetic deaths in a family", Br J Anaesth, 34, pp.395~396 (1962)
- Mahler DA, "The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes", Chest, 85, pp.751~758 (1984)
- Jacobi J, "Corticosteroid replacement in critically ill patients", Crit Care Clin, 22, pp.245~253 (2006)
- Rosenberg H, "Malignant hyperthermia", Orphanet J Rare Dis, 2, pp.21~ (2007)
- Larach MG, "A clinical grading scale to predict malignant hyperthermia susceptibility", Anesthesiology, 80, pp.771~779 (1994)
- Karan SM, "Malignant hyperthermia masked by capnographic monitoring", Anesth Analg, 78, pp.590~592 (1994)
- Hopkins PM, "Malignant hyperthermia: advances in clinical management and diagnosis", Br J Anaesth, 85, pp.118~128 (2000)
- 김태요, "Sevoflurane 마취 중 발생한 악성 고열증", Korean Journal of Anesthesiology, 47(3), pp.449~453 (2004), 대한마취과학회
- Litman RS, "Postoperative malignant hyperthermia: an analysis of cases from the North American malignant hyperthermia registry", Anesthesiology, 109, pp.825~829 (2008)
- Ording H, "In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects", Acta Anaesthesiol Scand, 41, pp.955~966 (1997), The European Malignant Hyperthermia Group
- Nelson TE, "Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications", Anesthesiology, 84, pp.1368~1379 (1996)
- hydantoins. A new class of muscle relaxants, "J Med Chem", 1967, 807~810
- Barrett PJ, "Ecstasy and dantrolene", BMJ, 305, pp.1225~ (1992)
- Ketel WB, "Long-term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function", Curr Med Res Opin, 9, pp.161~169 (1984)
- Marelli A, "The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature", Minerva Med, 87, pp.45~51 (1996)
- Krause T, "Dantrolene--a review of its pharmacology, therapeutic use and new developments", Anaesthesia, 59, pp.364~373 (2004)